期刊
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 323, 期 23, 页码 2365-2366出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jama.2020.8863
关键词
-
This Viewpoint reviews the FDA's May 2020 Emergency Use Authorization of the antiviral drug remdesivir for treatment of COVID-19 and discusses the need for a transparent distribution plan of a drug not otherwise available in the US and for which demand will likely exceed supply.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据